Merge Talks Between The EVERY Co and Onego Bio
Alt-egg startups The EVERY Company and Onego Bio were discussing a merger to create a new company with a valuation of $400m before talks fell apart.
The EVERY Co has urged a court in Wisconsin to dismiss a lawsuit from Onego Bio seeking to invalidate one of EVERY's patents.
Patent Dispute
The dispute centers on a “foundational” patent (‘784) from The EVERY Co covering ovalbumin expression in a range of hosts.
- The EVERY Co uses yeast (Komagataella phaffii) as its host microorganism.
- Onego Bio uses fungus (Trichoderma reesei).
The IP at issue covers the production of ovalbumin, the primary protein in egg white, via precision fermentation.
Author's summary: The EVERY Co and Onego Bio eyed $400m merger.
More News
- [collapsed adjective - Definition, pictures, pronunciation and ...]
- One Of EVE Online's Biggest Alliances Has Collapsed While EVE Player Numbers Surge
- Why Redwire Stock Collapsed 30% Last Month
- Leonard H. McCoy - Memory Alpha
- Disney World guest rescues collapsed man in latest medical emergency
- MCCOY definition and meaning | Collins English Dictionary
- Bills great calls out Brandon Beane for failing Josh Allen
- [Commissioner Dexter McCoy launches bid for Fort Bend County judge, citing need for new leadership]
- Rapala x Charlie's Fishing Limited Edition Super Shadow Rap Glide 11
- Tour news: Rosalía, Taskmaster, Don Letts & Daddy G, De La Soul, LCD Soundsystem, Amyl & The Sniffers, Lily Allen, more